𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

✍ Scribed by Rainer Enkelmann


Publisher
Springer
Year
1991
Tongue
English
Weight
673 KB
Volume
105
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Alprazolam SR in the treatment of genera
✍ M. Luisa Figueira πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

A multicentre, double-blind, randomized trial compared the ecacy of a sustained-release formulation of alprazolam with bromazepam in the treatment of generalized anxiety. One hundred and twenty-one outpatients were randomly assigned to three weeks of active treatment with alprazolam SR (2 mg once da

Alprazolam in the treatment of generaliz
✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage

Sudden gains in the treatment of general
✍ Julie Present; Paul Crits-Christoph; Mary Beth Connolly Gibbons; Bridget Hearon; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Abstract The objective of this study was to investigate the prevalence and timing of sudden gains over the course of brief, psychodynamically oriented treatment for generalized anxiety disorder (GAD). Data were used from two studies of brief (i.e., 16‐session) supportive‐expressive psychotherapy

Comparative study of short-term anxiolyt
✍ Kouji Yamauchi; Shigeto Yamada; Kiichirou Morita; Hisao Maeda; Masatoshi Tanaka πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

Anxiolytic potency of 1 week of treatment with alprazolam or tandospirone in psychiatric outpatients with anxiety disorders was evaluated by changes in the scores on the Hamilton Anxiety Scale and the State and Trait Anxiety Inventory and in the saliva level of free-3-methoxy-4-hydroxyphenylglycol (